Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Cameco, Applied Digital, West Pharmaceutical And More On CNBC's 'Final Trades'

Author: Avi Kapoor | November 18, 2024 08:55am

On CNBC's “Halftime Report Final Trades,” Tim Seymour of Seymour Asset Management picked Cameco Corporation (NYSE:CCJ).

On Nov. 7, Cameco posted a loss for the third quarter but raised its FY24 revenue guidance.

Julie Biel of Kayne Anderson Rudnick named West Pharmaceutical Services, Inc. (NYSE:WST), saying this health care trade is “overblown.”

On Oct. 24, West Pharmaceutical Services reported adjusted EPS of $1.85, down from $2.16 a year ago, beating the consensus of $1.50. The designer and manufacturer of injectable pharmaceutical packaging and delivery systems reported sales of $746.9 million, beating the consensus of $709.62 million.

Don't forget to check out ou premarket coverage here

Karen Finerman of Metropolitan Capital Advisors said she likes iShares Biotechnology ETF (NYSE:IBB) here.

Steven Grasso of Grasso Global Inc. named Applied Digital Corporation (NASDAQ:APLD) as his final trade.

Nvidia's (NASDAQ:NVDA) 13F fling, last week, showed it purchased 7.72 million Applied Digital shares worth $63.66 million as of Sept. 30, which translates into close to a 3.6% stake in Applied Digital, which had 215.36 million outstanding shares as of Oct. 8,

Price Action:

  • West Pharmaceutical shares dipped 7% to close at $314.49 on Friday.
  • Cameco shares gained by 0.9% to settle at $53.59 during Friday's session.
  • iShares Biotechnology ETF fell by 4.8% during Friday's session.
  • Applied Digital shares gained 5.4% to settle at $7.23.

Check This Out:

Image: Courtesy of Cameco

Posted In: APLD CCJ IBB NVDA WST

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist